TL;DR
ALA-PDT may be considered as a viable treatment option for women with type 3 TZ, persistent LSIL and high-risk HPV infection, and its benefit for patients with various clinical risk factors is suggested.
AI-generated by Semantic Scholar
Authors
Ruizhe Chen, Junfen Xu, Chun Ye, Lingjia Lu, Ying Li, Lingfang Wang, Xiaodong Cheng, Yunfeng Fu
Funding
National Natural Science Foundation of China
32300460
Zhejiang Province Natural Science Foundation
LQ23H160031